1 CD25 1 T cells of younger mice did not increase after stimulating them in vitro with anti-CD3 and -CD28. Thus, under these conditions, Helios could be considered a more reliable marker for distinguishing tTreg cells from pTreg cells than Nrp1. R egulatory T (Treg) cells play a pivotal role in maintaining the homeostasis of the immune system by; (1) secreting anti-inflammatory cytokines such as: interleukin-10 (IL-10), IL-35 and transforming growth factor-b (TGF-b), (2) producing granzyme A or B (3) increasing in the consumption of IL-2 to destruct effector T cells by metabolic disruption and (4) enhancing the dendritic cells to produce indoleamine 2,3-dioxygenase to suppress the effector T cells (reviewed in ref. [1] [2] [3] 1-3 . Treg cells express CD4 and CD25 in naïve conditions 4, 5 , and despite intensive research in the field of Treg cells, Foxp3 is still (together with CD4 and CD25) the main marker for detection of these cells [6] [7] [8] . There are several other markers that are also expressed by Treg cells such as CD103, CTLA-4, ICOS, glucocorticoid induced TNF-related protein (GITR), programmed cell death protein 1 (PD-1) and Swap70 4, [9] [10] [11] . However, these markers are unable to distinguish between thymic derived or natural Treg (tTreg) cells and peripherally induced Treg (pTreg) cells. Also, some of these markers (eg. CD103, CTLA-4, ICOS and PD-1) are upregulated in activated CD4
1 T cells 4, 9, 12, 13 . In 2010, Thornton et al. have reported that Helios, a member of the Ikaros family, is expressed by tTreg cells and that Helios could be used as a marker for distinguishing between tTreg cells and pTreg cells 14 . Recently, two other groups reported that Neuropilin-1 (Nrp1), a semaphorin III receptor, could be used as a marker for tTreg cells under certain conditions 11, 15 . Nrp1 was also earlier reported as a cell surface marker for mouse, but not human, Treg cells 16, 17 .
In the present study, we have extended a serendipitous observation of ours; we found that not all the Foxp3 
CD25
1 Treg cells did not differ much between the three organs, but in spleen these cells were slightly fewer than in thymus ( Fig. 2A, p (Fig. 2B ). The same pattern was also seen in PDLNs and spleen (Fig. 2B) . The proportion of Helios 1 cells among Foxp3 1 Treg cells was highest in thymus, followed by spleen, and lowest in PDLNs (Fig. 2B) . The Helios 1 cell proportion observed in Foxp3 1 Treg cells in thymus, PDLNs and spleen were very similar to previous findings 14 . These results indicate that Helios might be a better marker for detection of tTreg cells compared to Nrp1. Fig. 6A-F 
Nrp1
1 (white bar) T cells were analysed for Helios expression using flow cytometry (gating strategies are shown in Fig. 3 A-C) 
CD25
1 Treg cells in the thymic glands of NOD and C57BL/6 mice and got similar results in both strains (Fig. 2C ). In addition, the proportion of Helios 1 cells (100%) was higher than that of Nrp1 1 cells (,60%) in Foxp3 1 in the thymus of NOD and C57BL/6 mice (Fig. 2D) . In this study, we used NOD and C57BL/6 mice to further show that Helios expression is not mouse strain specific. The NOD murine model is widely used as spontaneous experimental mouse model for type 1 diabetes and was used to represent an autoimmune state, while C57BL/6 was used as a wild type mouse strain.
In thymus, 0.5% of CD4 
2 Foxp3 1 Treg cells to investigate the expression of these markers in the thymus. Interestingly, Helios expression (,100%) was much higher than Nrp1 expression (between ,0 and 30%) in the thymic glands of CD-1, NOD and C57BL/6 mice (Fig. 3) . 
1 cells of CD-1 mice were further analysed for individual expression of Nrp1, Helios or Foxp3 in thymus, PDLNs and spleen cells using flow cytometry (A). Thymic glands of NOD and C57BL/6 mice were examined similarly (C). Subsequently, CD4
1

CD8
2
CD25
1 cells were gated first for Foxp3, and then CD4
Foxp3
1 cells were analysed for either Helios or Nrp1 expression using FACS in CD-1 mice (B) and in thymus of NOD and C57BL/6 mice (D). Results are expressed as means 6 SEM, from two experiments (n 5 4-5 mice/experiment). *, ** and *** denote p , 0.05, p , 0.01 and p , 0.001, respectively. One-way ANOVA (A, B and C) and unpaired t-tests (D) were performed for comparisons.
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Since Nrp1 is a transmembrane protein 21, 22 , we investigated the intracellular staining of Nrp1 and found that approximately 50-60% of CD4
1
CD25
1 Foxp3 1 Treg cells were expressing Nrp1 intracellularly. These results also indicate that, Helios may be a more reliable marker than Nrp1 for detection of the tTreg cells in naïve conditions.
Helios
1 tTreg cells have a higher frequency of IL-10, Ebi3 and CTLA-4 than Nrp1 1 tTreg cells. We found that Helios seems to be a better marker for tTreg under certain conditions ( Fig. 2 and 3 Fig. 1-2) . Also, the proportion of CTLA-4
1 cells was higher in Helios 1 tTreg compared to Nrp1 1 tTreg cells of thymic glands and spleen, but not in PDLNs ( Fig. 4C and Supplementary Fig. 3 ). However, the expression of CTLA-4, as indicated by florescence intensity, was higher in Helios 1 tTreg than Nrp1 1 in PDLNs and spleen, but not in thymic glands (Fig. 4D) 23 . However, the expression of Bcl-2 is often used to determine the apoptotic stability or anti-apoptotic activity of Treg cells 24 , and we therefore analysed the expression of Bcl-2 in Helios 1 and Nrp1 1 tTreg cells using flow cytometry. We found that the expression of Bcl-2 was higher in Helios 1 tTreg in Nrp1 1 tTreg cells of thymic glands (Fig. 5A-B) . However, the expression of Bcl-2 was equal in Helios 1 and Nrp1 1 tTreg cells of PDLNs and spleen ( Fig. 5A-B 
2 pTreg cells in thymus, PDLNs and spleen, respectively (Fig.6 H) . On the contrary, 80%, 41% and 52% of Foxp3 
Nrp1
2 pTreg cells were Helios 1 (Fig. 6H) . These results indicate that when Helios is used as a tTreg cell marker a higher percentage of tTreg cells are detected than when using Nrp1 as a marker. CD4 , and (C) CTLA-4
Helios 1 (black bars) cells of thymic glands, PDLNs and spleen were analysed by using flow cytometry (gating strategies are shown in Suppl. fig. 1-3 Nrp1 expression starts at a later stage of the T cells development. We confirmed that all the Helios 1 tTreg cells were not expressing Nrp1 (Fig. 6 ) and that the apoptotic stability of Helios 1 tTreg cells was higher than Nrp1 1 tTreg cells in thymic glands (Fig. 5 ). This could be because the Nrp1 expression starts later in the development of T cells compared to Helios and Foxp3 expression. This notion is supported by our study of Foxp3, Nrp1 and Helios expression in CD4 1 CD8 2 T cells in thymus and spleen of 7 days old NOD mice. We did not see any CD4
1 CD8 2 T cells expressing Nrp1, but at the same time these cells were expressing Foxp3 and Helios (Fig. 7A-F fig. 4B ), indicating that these cells are mature cells and that the lack of Nrp-1 expression is not a sign of an immature status of the cells. We also investigated the expression in 3, 5, 7, 10 and 14 days old NOD mice and could confirm that the expression of Nrp1 in thymic CD4
Foxp3
1 Treg cells first starts between day 7 and 10 after birth ( Figure 7A-F (Fig. 7G-J) after TCR stimulation. The expression of Helios was not altered after the stimulation (Fig. 7K-L) . In this study, we used 7 days old NOD mice since Helios has shown a similar response in the thymus of NOD mice as in CD-1 mice thymus.
Discussion
The Ikaros family member Helios and semaphorin III receptor Nrp1 have been suggested as potential markers for distinguishing tTreg cells from pTreg cells 11, 14, 15 . However, in the present study, we found that the proportion of Helios 18 . Furthermore, to affirm that our data from the CD-1 mice was not strain biased, we investigated NOD and C57BL/6 mice. Interestingly, all the different mouse strains studied in this context showed a similar response. To the best of our knowledge this is the first study in vivo where Foxp3, Helios and Nrp1 have been investigated simultaneously in the thymic glands of naïve mice. However, Schliesser et al., have investigated in vitro co-expression of Nrp1 or Helios in Foxp3 1 alloreactive Treg (aTreg) cells generated from CD4
1 T cells co-cultured with TGF-b, anti-CD4 antibody and retinoic acid or rapamycin in vitro 27 . Their data are in line with our finding since they also found that 70% we detected in CD-1 mice thymic glands corresponds well with these data. Furthermore, Ayyoud et al. have suggested that ,10% Foxp3 
Helios
2 pTreg cells were not expressing Nrp1. This indicates that when Nrp1 is used as a marker for tTreg cell, Nrp1 does not detect many of the tTreg cells, but when Helios is used as a marker for tTreg cells, most of the tTreg cells are detected. Moreover, we did not detect any Foxp3 
Nrp1
2 Treg cells, suggesting that both of these Treg cells were mature. Taken together, our results support our hypothesis that Helios is a more suitable marker for tTreg cells than Nrp1. Also, Nrp1 has been suggested not to be a good marker to detect human Treg cells 17 . The expression of Helios has been reported to increase in activated and strongly autoreactive T cells, a finding that further challenge the suitability of Helios as a tTreg cell marker 33, 34 . Nevertheless, it has also been reported that Nrp1 is required for stability and functionality of Treg cells 23 . On the other hand, we found in the present study that the apoptotic stability of Helios 1 tTreg cells was higher than those of Nrp1 1 in thymic glands. Furthermore, there were a higher proportion of IL-10 35 . Altogether, our results indicate that both Helios and Nrp1 can be used as markers for tTreg cells, but that Nrp1 seems less suitable as a marker compared to Helios in naïve conditions. It could be that Nrp1 expression starts at a later stage of the T cell development since it has been reported that Helios expression precedes the Foxp3 expression in thymus 14 , a notion that is supported by our findings that Nrp1 is expressed after the Helios and Foxp3 in the Treg cells. An equal expression of GITR on Treg cells of 7 days old mice compared to Treg cells of adult mice suggest that the Treg cells in 7 days old mice were mature.
The delayed expression of Nrp1 on Treg cells led to the question of whether the expression of Nrp1 could be regulated by the TCR. In the present study, we found that TCR stimulation did not upregulate the expression of Nrp1, disproving this idea.
Furthermore, the anti-apoptotic activity of Nrp1 1 tTreg cells is lower compared to Helios 1 tTreg cells in the thymic glands and it seems that Helios 1 tTreg cells are functionally more active than Nrp1 1 tTreg cells. On the other hand, Nrp1 is an angiogenesis factor, and it is involved in enhancing a strong interaction between Treg cells and dendritic cells 36, 37 , which could be another reason that Nrp1 is not expressed by all the tTreg cells.
Methods
Animals. Male CD-1 mice were obtained from Charles River (Hannover, Germany). Female C57BL/6 mice were obtained from Taconic (Bomholt, Denmark). The NOD mice used were originally obtained from the Clea Company (Aobadi, Japan), and have subsequently been inbred under pathogen-free conditions at the animal department, Biomedical Center, Uppsala, Sweden. The use of animals was in accordance with international guidelines (NIH publications 85-23) and the local animal ethics committee at Uppsala University approved the animal experiments. Cell isolation from thymic glands, PDLNs and spleens. Single cell suspensions of spleen tissue were made as previously described 38 . Also, single cell suspensions of thymic glands were prepared in the same manner as spleen cell suspensions. PDLNs were dissected and ground through a mesh to release the cells and then washed with RPMI medium (Sigma Aldrich, St Louis, MO, USA). The cell suspensions were washed, all the cell suspensions were counted using FACSCalibur (Becton, Dickinson and Company (BD), Franklin Lakes, NJ, USA) and 1 3 10 6 cells were used for flow cytometry staining.
CD4
1
CD25
2 T cells and CD4
1
CD25
1 Treg cells sorting. Single cell suspension of the thymic glands of 7 days old mice were prepared, followed by sorting of the CD4
1
CD25
1
CD25
1 Treg cells using the Miltenyi Biotec magnetic sorter (Miltenyi Biotec, Germany) and CD4
1 CD25 1 T cell isolation kit (Miltenyi Biotec), following the manufacture's instruction.
In vitro stimulation. Sorted 5 3 10 4 CD41CD25-or CD41CD251 T cells were cultured in 96-well flat bottom plates with RPMI 1640 (Sigma) supplemented with antibiotics. The cells were stimulated with plate-bound anti-CD3 (1 mg/ml) and soluble anti-CD28 (1 mg/ml) for 3 days.
Flow cytometry. Thymus, PDLNs and spleen cells were stained with the following surface antibodies; FITC-conjugated anti-CD4 (RM4-5, eBioscience, San Diego, Carlifornia, USA), APC-H7-conjugated anti-CD8 (53-6.7, BD), BV605-, PE-or PBconjugated anti-CD25 (PC61.5, Biolegend, San Diego, Carlifornia, USA or eBioscience), eFlour405-conjugated anti-CD44 (IM7, eBioscience) and APC-or PEconjugated anti-Nrp1 (761705, R&D, Minneapolis, MN, USA). Then the cells were washed, fixed and permeabilized using the Mouse Regulatory T Cell Staining Kit #3 (eBioscience). The permeabilized cells were stained with APC-or PECy-7-conjugated Foxp3 (FJK -16s, eBioscience), APC-or PB-conjugated Helios (22F6, BioLegend), PE-conjugated IL-10 (JES5-16E3, BioLegend), PE-conjugated CTLA-4 (UC10-4B9, BioLegend), PE-conjugated Bcl-2 (BCL/10C4, BioLegend), PE-conjugated GITR (Biolegend) and PE-conjugated Ebi3 (355022, R&D). The stained cells were analysed on a BD LSRII Flow Cytometer (BD) at BioVis Uppsala University, Uppsala, Sweden. The data were analysed by using Diva 6.0 software (BD) or Flowlogic (eBioscience). Single stained and fluorescence minus one-stained controls were used for gating strategies.
Statistical analysis. The results were expressed as means 6 SEM. SigmaPlot TM 12.3 software was used for the statistical analysis. Unpaired t-tests were used for comparisons between two groups. One-way ANOVA followed by Tukey's test were performed for multiple comparisons. A p-value of ,0.05 was considered to be significant.
